ES2154551B1 - Nuevos derivados de tetrazol como agentes antidiabeticos. - Google Patents

Nuevos derivados de tetrazol como agentes antidiabeticos.

Info

Publication number
ES2154551B1
ES2154551B1 ES9801650A ES9801650A ES2154551B1 ES 2154551 B1 ES2154551 B1 ES 2154551B1 ES 9801650 A ES9801650 A ES 9801650A ES 9801650 A ES9801650 A ES 9801650A ES 2154551 B1 ES2154551 B1 ES 2154551B1
Authority
ES
Spain
Prior art keywords
sub
antidiabetic agents
tetrazol
new derivatives
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9801650A
Other languages
English (en)
Other versions
ES2154551A1 (es
Inventor
Castillo Nieto Juan Carlos Del
Freixa Maria Chalaux
Clotet Joan Huguet
Mancini Marisa Mourelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES9801650A priority Critical patent/ES2154551B1/es
Publication of ES2154551A1 publication Critical patent/ES2154551A1/es
Application granted granted Critical
Publication of ES2154551B1 publication Critical patent/ES2154551B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos derivados de tetrazol como agentes antidiabeticos. La presente invención se refiere a compuestos de fórmula (I), **FORMULA01** en la que: m = 1-5; n = 1-3; X es -O-, ó - NR{sub,1}; R{sub,1} es H, alquilo C{sub,1}-C{sub,6}, arilo o aralquilo; Ar es A, B, C o D, donde: Y es O ó S; R{sub,2} es - NH{sub,2}, -NO{sub,2}; R{sub,3} y R{sub,4} son independientemente H, alquilo C{sub,1}-C{sub,6}, alquenilo C{sub,2}-C{sub,6}, OH, OR{sub,5}, NH{sub,2}, NR{sub,5}, N0{sub,2}, halógeno (F, Cl, Br, I), ó CO-R{sub,5}, o bien forman conjuntamente un anillo aromático fusionado substituido o no substituido, siendo R{sub,5} un H, alquilo C{sub,1}-C{sub,6}, arilo, o aralquilo; a sus posibles sales farmacéuticamente aceptables, formas tautómeras, a un procedimiento para su obtención y a su uso para la fabricación de un medicamento. Los compuestos de la presente invención presentan una elevada actividad hipoglucemiante.
ES9801650A 1998-08-03 1998-08-03 Nuevos derivados de tetrazol como agentes antidiabeticos. Expired - Fee Related ES2154551B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9801650A ES2154551B1 (es) 1998-08-03 1998-08-03 Nuevos derivados de tetrazol como agentes antidiabeticos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9801650A ES2154551B1 (es) 1998-08-03 1998-08-03 Nuevos derivados de tetrazol como agentes antidiabeticos.

Publications (2)

Publication Number Publication Date
ES2154551A1 ES2154551A1 (es) 2001-04-01
ES2154551B1 true ES2154551B1 (es) 2001-10-16

Family

ID=8304752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9801650A Expired - Fee Related ES2154551B1 (es) 1998-08-03 1998-08-03 Nuevos derivados de tetrazol como agentes antidiabeticos.

Country Status (1)

Country Link
ES (1) ES2154551B1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958355B2 (en) 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) * 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
WO2002024689A1 (en) 2000-09-21 2002-03-28 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845231A (en) * 1988-02-12 1989-07-04 American Home Products Corporation Tetrazoles and their use as hypoglycemic agents
KR930701436A (ko) * 1990-07-03 1993-06-11 오노다 마사아이 비스헤테로환 화합물
US5591862A (en) * 1993-06-11 1997-01-07 Takeda Chemical Industries, Ltd. Tetrazole derivatives, their production and use
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists

Also Published As

Publication number Publication date
ES2154551A1 (es) 2001-04-01

Similar Documents

Publication Publication Date Title
DK0628311T3 (da) Xanthinderivater som antidepressive midler
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
DE69310501D1 (de) Chinolylbenzofuran derivate als leukotrien-antagonisten
EA200100487A1 (ru) Производные 2-аминотиазола, способ их получения и применение указанных веществ в качестве противоопухолевых средств
BRPI0213243B8 (pt) composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
AR007030A1 (es) Un compuesto derivado de indol, su uso, un procedimiento para producirlo, y una composicion farmaceutica que lo contiene
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
DK0649418T3 (da) 7-(2-aminoethyl)benzothiazolon
SE0101579D0 (sv) New compounds
DE69401716D1 (de) Imidazo [1,2-a] pyrasin-4-on-derivate welche als ampa und nmda receptor antagonisten dienen
ECSP045420A (es) Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
SE9300657D0 (sv) New compounds
FI951555A0 (fi) 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
ES2154551B1 (es) Nuevos derivados de tetrazol como agentes antidiabeticos.
ES512574A0 (es) "procedimiento de preparacion de derivados carboxilato".
NO961404L (no) 4-indolylpiperazinyl-derivater
MX25858A (es) 3-[1-tiazolidinilbutil-4-piperazinil]-1h-indazolesun procedimiento para su preparacion y su uso comomedicamentos.
ATE293616T1 (de) 2-fluoro-(oxido-thiopyran-4-yl)benzol derivate
HU9602534D0 (en) Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
HUP0400304A2 (hu) Dihidroimidazo[5,1-a]-béta-karbolin-származékok, előállításuk és gyógyszerként való alkalmazásuk
DE69407227D1 (de) Die Verwendung von 2-Phenylmethylene-1-3'-(amino)-2-(hydroxy)-propoxy-imino-cyclohexane-Derivaten

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010401

Kind code of ref document: A1

Effective date: 20010401

FD1A Patent lapsed

Effective date: 20050804